Literature DB >> 21533006

Mitogenic Signaling by the gep Oncogene Involves the Upregulation of S-Phase Kinase-Associated Protein 2.

Rangasudhagar Radhakrishnan1, Ji Hee Ha, Danny N Dhanasekaran.   

Abstract

The gep oncogene, defined by the activated mutant of the α-subunit of the G protein G(12) (Gα(12)Q229L or Gα(12)QL), potently stimulates the proliferation of many different cell types in addition to inducing neoplastic transformation of several fibroblast cell lines. While it has been demonstrated that Gα(12)QL accelerates G1- to S-phase cell cycle progression, the precise mechanism through which Gα(12) communicates to cell cycle machinery is largely unknown. In the present study, we report that the activated-mutational as well as receptor-mediated-Gα(12) transmits its proliferative signals to cell cycle machinery by modulating the levels of the S-phase kinase-associated protein 2 (Skp2), an E3 ubiquitin ligase, involved in the regulation of the cyclin-dependent kinase inhibitor (CKI), p27(Kip1). Our results show that the expression of Gα(12)QL leads to an increase in the levels of Skp2 with a correlatable decrease in p27(Kip1) levels and subsequent increase in the activities of specific CDKs. By demonstrating that the transient expression of Gα(12)QL induces an increase in Skp2 levels with resultant downregulation of p27(Kip1) in both NIH3T3 and human astrocytoma 1321N1 cells, we establish here that the effect of Gα(12) on Skp2/p27(Kip1) is cell type independent. In addition, we demonstrate that LPA-stimulated proliferation and changes in Skp2 and p27(Kip1) levels in 1321N1 cells could be inhibited by the expression of a dominant-negative mutant of Gα(12), thereby pointing to the critical role of Gα(12) in LPA-mediated mitogenic signaling. Our findings also indicate that LPA as well as Gα(12)-mediated upregulation of Skp2 requires a yet to be characterized mechanism involving JNK. Since Skp2 has been identified as an oncogene, and it is overexpressed in many cancers, our results presented here describe for the first time that Skp2 is a novel target in the cell cycle machinery through which Gα(12) and its cognate receptors transmit their oncogenic signals.

Entities:  

Keywords:  G12; JNK; LPA; Skp2; oncogene

Year:  2010        PMID: 21533006      PMCID: PMC3083023          DOI: 10.1177/1947601910390516

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  61 in total

1.  G alpha minigenes expressing C-terminal peptides serve as specific inhibitors of thrombin-mediated endothelial activation.

Authors:  A Gilchrist; J F Vanhauwe; A Li; T O Thomas; T Voyno-Yasenetskaya; H E Hamm
Journal:  J Biol Chem       Date:  2001-03-26       Impact factor: 5.157

Review 2.  CDK inhibitors: cell cycle regulators and beyond.

Authors:  Arnaud Besson; Steven F Dowdy; James M Roberts
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

3.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 4.  Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Authors:  Shuyu Li; Shuguang Huang; Sheng-Bin Peng
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

5.  Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.

Authors:  Rashmi N Kumar; Ji Hee Ha; Rangasudhagar Radhakrishnan; Danny N Dhanasekaran
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo.

Authors:  Marius Grzelinski; Olaf Pinkenburg; Thomas Büch; Maike Gold; Stefanie Stohr; Hermann Kalwa; Thomas Gudermann; Achim Aigner
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 12.531

Review 7.  Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer?

Authors:  Mark A Hull; Stanley C W Ko; Gillian Hawcroft
Journal:  Mol Cancer Ther       Date:  2004-08       Impact factor: 6.261

8.  Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB.

Authors:  Hui-Kuan Lin; Guocan Wang; Zhenbang Chen; Julie Teruya-Feldstein; Yan Liu; Chia-Hsin Chan; Wei-Lei Yang; Hediye Erdjument-Bromage; Keiichi I Nakayama; Stephen Nimer; Paul Tempst; Pier Paolo Pandolfi
Journal:  Nat Cell Biol       Date:  2009-03-08       Impact factor: 28.824

Review 9.  Gastrins, cholecystokinins and gastrointestinal cancer.

Authors:  Ahmad Aly; Arthur Shulkes; Graham S Baldwin
Journal:  Biochim Biophys Acta       Date:  2004-07-06

Review 10.  Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer.

Authors:  Dan D Hershko
Journal:  Cancer       Date:  2008-04-01       Impact factor: 6.860

View more
  6 in total

1.  The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Authors:  Ji Hee Ha; Jeremy D Ward; Lakshmi Varadarajalu; Sang Geon Kim; Danny N Dhanasekaran
Journal:  Cell Signal       Date:  2013-09-19       Impact factor: 4.315

2.  Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Gα(12).

Authors:  Zachariah G Goldsmith; Ji Hee Ha; Muralidharan Jayaraman; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2011-05

3.  Neoplastic transformation induced by the gep oncogenes involves the scaffold protein JNK-interacting leucine zipper protein.

Authors:  Kimia Kashef; Rangasudhagar Radhakrishnan; Clement M Lee; E Premkumar Reddy; Danny N Dhanasekaran
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

4.  The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.

Authors:  Jacob A Gardner; Ji Hee Ha; Muralidharan Jayaraman; Danny N Dhanasekaran
Journal:  Pancreas       Date:  2013-07       Impact factor: 3.327

5.  Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer.

Authors:  Ji-Hee Ha; Muralidharan Jayaraman; Mingda Yan; Padmaja Dhanasekaran; Ciro Isidoro; Yong-Sang Song; Danny N Dhanasekaran
Journal:  Oncol Lett       Date:  2021-08-10       Impact factor: 2.967

6.  Determinant role for the gep oncogenes, Gα12/13, in ovarian cancer cell proliferation and xenograft tumor growth.

Authors:  Ji Hee Ha; Rohini Gomathinayagam; Mingda Yan; Muralidharan Jayaraman; Rajagopal Ramesh; Danny N Dhanasekaran
Journal:  Genes Cancer       Date:  2015-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.